teriparatide vs semaglutide Tirzepatide vs Liraglutide Retatrutide vs Tirzepatide vs Semaglutide:

Foods that worsen gas, bloating, and sulfur burps on GLP-1 medications are typically large, high-fat, or highly fermentable meals , which are more likely to exacerbate delayed gastric emptying and microbial gas production

Sunmarket Wellness We display own reviews and reviews from external platforms to help you make purchasing decisions with useful, clear information based on real experiences

Timeline and Prevalence of GLP-1 Gastrointestinal Side Effects Gastrointestinal side effects from GLP-1 therapy are common but often temporary

Anyone monitoring for retatrutide-related hair loss should understand that this typically relates to rapid weight loss rather than direct drug toxicity, and it generally resolves as weight stabilizes

The most important effect of GLP-1 is to increase insulin secretion after a meal, and this effect is dependent on glucose concentration, so despite promoting insulin secretion, the occurrence of hypoglycemia is rare [25]

Patients should be encouraged to: Follow a balanced, portion-controlled diet emphasising whole grains, vegetables, lean proteins, and healthy fats Engage in regular physical activity (at least 150 minutes of moderate-intensity exercise weekly, as per NICE guidance) [3] Stay well-hydrated to minimise gastrointestinal side effects Avoid excessive alcohol consumption , which can impair glucose regulation Patient safety advice includes recognising when to seek medical attention: Contact your GP or diabetes nurse if experiencing persistent nausea/vomiting preventing adequate nutrition or hydration Contact NHS 111 or seek urgent medical advice for severe abdominal pain (potential pancreatitis or gallbladder disease, though rare) Report visual changes or symptoms of diabetic retinopathy progression Seek emergency care (A&E) for persistent vomiting with reduced urine output, or for persistent hyperglycaemia with ketones Attend scheduled follow-up appointments for HbA1c monitoring (typically at 36 months) Patients should be reassured that gradual glucose improvement is expected and appropriate , and that working collaboratively with their healthcare team optimises outcomes whilst minimising risks